Emerging evidence demonstrates persistent cardiovascular and pulmonary alterations in long COVID patients, indicating a need for integrated diagnostics and management.
Key Points
Patients with long COVID exhibit significant cardiovascular and pulmonary complications, including varied inflammatory responses and potential tissue damage.
Elevated levels of pro-inflammatory cytokines, such as IL-6, contribute to a prothrombotic state and heightened risk of chronic complications.
Diagnostic strategies should incorporate molecular and histopathological assessments to effectively evaluate cardio-pulmonary health post COVID-19.
Recognizing the interrelation between pulmonary fibrosis and cardiac dysfunction underscores the necessity for multidisciplinary care approaches.